费解
发表于 2025-3-28 14:50:29
Adaptive Trial Design in Clinical Research,ibility and efficiency. Based on adaptations applied, adaptive designs can be classified into three categories: prospective, concurrent, and retrospective adaptive designs. An adaptive design is flexible in modifying trial and/or statistical procedures of on-going clinical trials. However, it is a c
coagulate
发表于 2025-3-28 20:44:21
Best Practices in Clinical Trial Simulations for Adaptive Study Designs,imulation has been used extensively in many areas such as aerospace engineering, weather prediction and automotive design. In recent years, simulation has become much more mainstream in clinical trial design. Simulated clinical trials are used to gain a much richer understanding of how a trial will
panorama
发表于 2025-3-29 00:52:48
http://reply.papertrans.cn/19/1884/188312/188312_43.png
羊栏
发表于 2025-3-29 06:08:02
http://reply.papertrans.cn/19/1884/188312/188312_44.png
airborne
发表于 2025-3-29 08:03:36
Phase I Cancer Clinical Trial Design: Single and Combination Agents, novel designs, including the continual reassessment method (CRM), the Bayesian model averaging CRM (BMA-CRM), the modified toxicity probability interval (mTPI) design, the Bayesian optimal interval (BOIN) design, and the Keyboard design. We discuss the pros and cons of these designs. Numerical stud
ABHOR
发表于 2025-3-29 12:29:01
Data Monitoring: Structure for Clinical Trials and Sequential Monitoring Procedures,ience with the conduct of other types of studies on human populations. Interim data monitoring, however, is often unfamiliar territory even to investigators who have been involved with other aspects of clinical trials. Yet there is some general agreement based on long experience, and some published
背带
发表于 2025-3-29 16:16:12
http://reply.papertrans.cn/19/1884/188312/188312_47.png
嘲弄
发表于 2025-3-29 20:23:07
Multi-Regional Clinical Trials, ICH-E17, and Subpopulations,ng in multiple regions using the same trial data in inside and outside of ICH (international council of harmonization) regions (Regions considered as ICH are European Union, US, Japan, Canada, and Switzerland).
委派
发表于 2025-3-30 00:51:55
Patient-Reported Outcome Measures: Development and Psychometric Evaluation,easures specifically designed to assess key endpoints in clinical trials, with the ultimate goal of supporting approval and/or labeling claims for pharmaceutical products. While many of our recommendations are broadly applicable to the development of PRO measures for use in clinical trials in any co
送秋波
发表于 2025-3-30 06:29:17
http://reply.papertrans.cn/19/1884/188312/188312_50.png